| |
 

Regulation Getting Clinical

March 29, 2012

Executive Summary

Legal experts discussed two recent challenges involving Reebok and Dannon. Both cases dealt with multi-forum disputes, as well as the introduction of a new definition of “competent and reliable scientific evidence” by the Federal Trade Commission. Both Reebok and Dannon reached settlements in their cases, but these challenges may have lasting legal implications for the industry as a whole.

Related handouts:

Source

“Regulation Getting Clinical.” Nancy Dowling, General Counsel, The Dannon Company, Inc.; Randal M. Shaheen, Partner, Venable LLP; Sarah Stuart, Associate General Counsel, Reebok International Ltd.; Douglas J. Wood, Partner, Reed Smith LLP. ANA Advertising Law and Public Policy Conference, 03/29/12.

Relevant Topics